Clearstead Advisors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-23
Closed -$327 – 2245
2025
Q4
$327 Buy
23
+21
+1,050% +$397 ﹤0.01% 2365
2025
Q3
$50 Sell
2
-262
-99% -$5.85K ﹤0.01% 2977
2025
Q2
$5.99K Buy
+264
New +$6.26K ﹤0.01% 2058

Other funds holding ACHC

Clearstead Advisors's ACHC Position: Q1 2026 in Review

Clearstead Advisors sold out of Acadia Healthcare (ACHC) in Q1 2026, closing a stake of 23 shares — an estimated $327 sold.

Clearstead Advisors first reported a position in ACHC in Q2 2025 and held it in 3 quarters. The position peaked at $5.99K in Q2 2025. 296 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Clearstead Advisors reported no remaining Acadia Healthcare position as of Q1 2026 after selling out during the quarter.
  • Clearstead Advisors sold 23 Acadia Healthcare shares in Q1 2026, an estimated $327.
  • Clearstead Advisors first reported a position in Acadia Healthcare in Q2 2025 and held it in 3 quarters.
  • Clearstead Advisors's Acadia Healthcare position peaked at $5.99K in Q2 2025.
  • 296 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.